Respiratory Virus Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030

Respiratory Virus Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030

Respiratory Virus Vaccine Trends and Forecast

The future of the global respiratory virus vaccine market looks promising with opportunities in the physician office, hospital, clinic, and pharmacy/store markets. The global respiratory virus vaccine market is expected to reach an estimated $13.5 billion by 2030 with a CAGR of 7.4% from 2024 to 2030. The major drivers for this market are rising rate of respiratory viral infections, growing awareness of vaccine benefits, and increasing government spending to fast track the development of vaccines and ensure widespread access.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Respiratory Virus Vaccine by Segment

The study includes a forecast for the global respiratory virus vaccine by type, route of administration, indication, end use, and region.

Respiratory Virus Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Inactivated/Killed
• Live-Attenuated
• Recombinant

Respiratory Virus Vaccine Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:

• Intramuscular
• Intranasal
• Subcutaneous

Respiratory Virus Vaccine Market by Indication [Shipment Analysis by Value from 2018 to 2030]:

• Influenza
• Measles
• Mumps & Rubella
• Coronavirus

Respiratory Virus Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Physician Offices
• Hospitals
• Clinics
• Pharmacies/Stores
• Others

Respiratory Virus Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Respiratory Virus Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies respiratory virus vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the respiratory virus vaccine companies profiled in this report include-

• Sanofi
• AstraZeneca
• Merck
• GlaxoSmithKline
• Serum Institute of India
• Moderna
• Bavarian Nordic

Respiratory Virus Vaccine Market Insights

Lucintel forecasts that inactivated/killed is expected to witness highest growth over the forecast period due to its ability to stimulate a powerful and enduring immune response.

Within this market, hospital is expected to witness highest growth over the forecast period.

North America is expected to witness highest growth over the forecast period due to strong healthcare infrastructure and government funding.

Features of the Global Respiratory Virus Vaccine Market

Market Size Estimates: Respiratory virus vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Respiratory virus vaccine market size by various segments, such as by type, route of administration, indication, end use, and region in terms of ($B).

Regional Analysis: Respiratory virus vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, route of administrations, indications, end uses, and regions for the respiratory virus vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the respiratory virus vaccine market.

Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q.1 What is the respiratory virus vaccine market size?

Answer: The global respiratory virus vaccine market is expected to reach an estimated $13.5 billion by 2030.

Q.2 What is the growth forecast for respiratory virus vaccine market?

Answer: The global respiratory virus vaccine market is expected to grow with a CAGR of 7.4% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the respiratory virus vaccine market?

Answer: The major drivers for this market are rising rate of respiratory viral infections, growing awareness of vaccine benefits, and increasing government spending to fast track the development of vaccines and ensure widespread access.

Q4. What are the major segments for respiratory virus vaccine market?

Answer: The future of the respiratory virus vaccine market looks promising with opportunities in the physician office, hospital, clinic, and pharmacy/store markets.

Q5. Who are the key respiratory virus vaccine market companies?

Answer: Some of the key respiratory virus vaccine companies are as follows:

• Sanofi
• AstraZeneca
• Merck
• GlaxoSmithKline
• Serum Institute of India
• Moderna
• Bavarian Nordic

Q6. Which respiratory virus vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that inactivated/killed is expected to witness highest growth over the forecast period due to its ability to stimulate a powerful and enduring immune response.

Q7. In respiratory virus vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to strong healthcare infrastructure and government funding.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the respiratory virus vaccine market by type (inactivated/killed, live-attenuated, and recombinant), route of administration (intramuscular, intranasal, and subcutaneous), indication (influenza, measles, mumps & rubella, and coronavirus), end use (physician offices, hospitals, clinics, pharmacies/stores, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?

Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Please note: It will take 2-3 business days to deliver the report upon receipt the order.